DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements

International Journal of Clinical Practice

Volumn 60, Issue 10, 2006, Pages 1187-1193

  Demirbag, Recep ^a   Yilmaz, R ^a   Gur, M ^a   Celik, H ^a   Guzel, S ^a   Selek, S ^a   Kocyigit, A ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

DNA damage; Metabolic syndrome; Total antioxidant capacity

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; PEROXIDE; TROLOX C;

ADULT; AEROBIC METABOLISM; AGE; AGED; ANALYSIS OF VARIANCE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; FEMALE; HUMAN; HUMAN CELL; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; METABOLIC DISORDER; METABOLIC PARAMETERS; METABOLIC SYNDROME X; OXIDATION; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIOXIDANTS; CASE-CONTROL STUDIES; COMET ASSAY; DNA DAMAGE; FEMALE; HUMANS; LYMPHOCYTES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDES;

EID: 33748577187     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01042.x     Document Type: Article

References (31)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
2. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F-29F.
3. Meigs JB. Epidemiology of the metabolic syndrome. Am J Manag Care 2002; 8: S283-92.
4. Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D. Advancing age and insulin resistance: New facts about an ancient history. Eur J Clin Investig 1999; 29: 758-69.
5. Demirbag R, Yilmaz R, Kocyigit A. Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat Res 2005; 570: 197-203.
6. Demirbag R, Yilmaz R, Gur M et.al. Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat Res 2005; 578: 298-307.
7. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001; 54: 176-86.
8. Andreassi MG. Coronary atherosclerosis and somatic mutations: An overview of the contributive factors for oxidative DNA damage. Mutat Res 2003; 543: 67-86.
9. Botto N, Masetti S, Petrozzi L et.al. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis 2002; 13: 269-74.
10. Collins AR. Oxidative DNA damage, antioxidants, and cancer. Bioessays 1999; 21: 238-46.
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
12. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-9.
13. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988; 175: 184-91.
14. Koracevic D, Koracevic G, Djordjevic V et.al. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001; 54: 356-61.
15. Demirbag R, Yilmaz R, Erel O et.al. The relationship between potency of oxidative stress and severity of dilated cardiomyopathy. Can J Cardiol 2005; 21: 851-5.
16. Kendall DM, Harmel AP. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: Understanding to role of insulin resistance. Am J Manage Care 2002; 8: S635-53.
17. Trevisan M, Browne R, Ram M et.al. Correlates of markers of oxidative status in the general population. Am J Epidemiol 2001; 154: 348-56.
18. Inoguchi T, Li P, Umeda F et.al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000; 49: 1939-45.
19. Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J Diabetes Complicat 2001; 15: 203-10.
20. Lee KU. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 2001; 54: S29-33.
21. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 2002; 5: 561-8.
22. Halliwell B. Free radicals, antioxidants and human disease: Curiosity, cause or consequence ? Lancet 1994; 344: 721-4.
23. Riccardi G, Aggett P, Brighenti F et.al. PASSCLAIM-body weight regulation, insulin sensitivity and diabetes risk. Eur J Nutr 2004; 43 (Suppl 2): II7-46.
24. Andreassi MG, Botto N, Rizza A et.al. Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 2002; 40: 862-8.
25. Harangi M, Remenyik E, Seres I et.al. Determination of DNA damage induced by oxidative stress in hyperlipidemic patients. Mutat Res 2002; 513: 17-25.
26. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361-70.
27. Negishi H, Ikeda K, Kuga S et.al. The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania. J Hypertens 2001; 19: 529-33.
28. Beltowski J, Wojcicka G, Gorny D, Marciniak A. The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol 2000; 51: 883-96.
29. Goukassian D, Gad F, Yaar M et.al. Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J 2000; 14: 1325-34.
30. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547-81.
31. Maritim AC, Sanders RA, Watkins JB. III Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2003; 17: 24-38.